Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study.

@article{Cai2009SerenoaRA,
  title={Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study.},
  author={Tommaso Cai and Sandra Mazzoli and Adriano Bechi and Patrizia Addonisio and Nicola Mondaini and Roberto Castricchi Pagliai and Riccardo Bartoletti},
  journal={International journal of antimicrobial agents},
  year={2009},
  volume={33 6},
  pages={
          549-53
        }
}
We report the results of a prospective randomised study to evaluate the therapeutic effect of Serenoa repens, Urtica dioica (ProstaMEV), quercitin and curcumin (FlogMEV) extracts associated with prulifloxacin in patients affected by chronic bacterial prostatitis (CBP). From a whole population of 284 patients, 143 patients affected by CBP [National Institutes of Health (NIH) class II prostatitis] were enrolled. All patients received prulifloxacin 600 mg daily for 14 days, in accordance with… Expand
Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients.
  • T. Cai, D. Tiscione, +5 authors G. Malossini
  • Medicine
  • Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
  • 2016
TLDR
The combination of serenoa repens, selenium, lycopene + bromelain and methylsulfonylmethane extracts improved the clinical efficacy of levofloxacin in patients affected by CBP without the development of side effects. Expand
Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®)
TLDR
Broad band, short-lasting antibiotic therapy in association with a nutritional supplement show better control and recurrence rate on patients affected by chronic bacterial prostatitis in comparison with antibiotic treatment alone. Expand
Multitargeted protective effect of Abacopteris penangiana against carrageenan-induced chronic prostatitis in rats.
TLDR
Results suggest that AHT and TFA have anti-prostatitis properties via inhibiting oxidative stress, NF-κB dependent pro-inflammatory cytokines, fibrosis-related factors and antinociceptive activity, suggesting that AP represents a potential herb for the treatment of prostatitis. Expand
Prulifloxacin: a review focusing on its use beyond respiratory and urinary tract infections.
TLDR
Prulifloxacin appears to be a promising agent for the treatment of bacterial prostatitis and traveller's diarrhoea. Expand
Prulifloxacin versus Levofloxacin in the Treatment of Respiratory and Urinary Tract Infections: A Multicentre, Double-Blind, Randomized Controlled Clinical Trial
TLDR
The cure rate and efficacy rate of respiratory and urinary tract infections of the levofloxacin group were better than those of the prulifloxAcin group, however, the difference between the 2 groups was not statistically significant (p > 0.05). Expand
Effectiveness on urinary symptoms and erectile function of Prostamev Plus® vs only extract Serenoa repens.
TLDR
The groupstreated with Prostamev Plus® in comparison to the groups treated with Serenoa repens extract (saw palmetto) achieved better improvements of both IPSS score, urinary flow and sexual life. Expand
The Effect of Flavonoids on Chronic Prostatitis: A Meta-analysis of Published Randomized Controlled Trials.
TLDR
It is indicated that the flavonoids may be clinically beneficial through significantly improving the response rate and NIH-CPSI in chronic prostatitis patients and short-lasting antibiotics therapy in association with the Flavonoids could be a better choose for CBP. Expand
Antimicrobial therapy for chronic bacterial prostatitis.
TLDR
Alternative antimicrobial agents tested for the treatment of CBP caused by traditional pathogens are co-trimoxazole, beta-lactams and tetracyclines, but no conclusions can be drawn regarding the optimal treatment duration of fluoroquinolones. Expand
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
TLDR
Curcumin has shown protection against hepatic conditions, chronic arsenic exposure, and alcohol intoxication, and dose-escalating studies have indicated the safety of curcumin at doses as high as 12 g/day over 3 months. Expand
Treatment of Bacterial Prostatitis: Clinico-Pharmacological Considerations
TLDR
The currently recommended treatment protocols will be summarized, and a number of potential alternative agents, that may become important in the near future due to the increasing chemoresistance rates worldwide, will be reviewed. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 35 REFERENCES
Synergistic effect between lycopene and ciprofloxacin on a chronic bacterial prostatitis rat model.
TLDR
Results suggest that lycopene may have an additional (synergistic) effect with ciprofloxacin in the treatment of CBP, and this could have an anti-inflammatory effect via an antioxidative function. Expand
Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome.
TLDR
Long-term improvement of signs and symptoms of prostatitis indicates that combination therapy is beneficial for symptomatic patients showing evidence of infection by unusual pathogens at the prostatic level, and supports the hypothesis that organisms other than the traditionally recognized uropathogens may play a role in the onset of prost atitis. Expand
Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis.
TLDR
Results indicate that about 20% of patients enrolled in this study, who were refractory to a protocol of 6-week combination therapy, could be 'rescued' by a second cycle of treatment, thus rapidly decreasing the impact of the disease on the quality of life of patients. Expand
Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa).
  • N. Chainani-Wu
  • Medicine
  • Journal of alternative and complementary medicine
  • 2003
TLDR
Curcumin has been demonstrated to be safe in six human trials and has demonstrated anti- inflammation activity and may exert its anti-inflammatory activity by inhibition of a number of different molecules that play a role in inflammation. Expand
Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis.
TLDR
Clinically acceptable short and long-term microbiological and clinical responses to fluoroquinolone therapy for clinical prostatitis did not depend on whether traditional uropathogenic bacteria or nontraditional uropATHogens were isolated in prostate specific specimens. Expand
Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study.
TLDR
Isolation of a high proportion of gram-positive organisms, as well as gram-negative pathogens, underscores the necessity of choosing an antimicrobial agent with broad-spectrum activity. Expand
A comprehensive review on the stinging nettle effect and efficacy profiles. Part II: urticae radix.
TLDR
A small number of randomised controlled studies indicate that a proprietary methanolic extract is effective in improving BPH complaints, however, the significance and magnitude of the effect remains to be established in further confirmatory studies before nettle root treatment may be accepted in the guidelines for BPH treatment. Expand
Interleukin 8 and anti-chlamydia trachomatis mucosal IgA as urogenital immunologic markers in patients with C. trachomatis prostatic infection.
TLDR
The results clearly highlight the role of immune system activation in the pathophysiology of CP/CPPS and that seminal IL-8 and mucosal IgA levels specific to CT antigens appear to be the best immunologic markers of chronic chlamydial prostatitis status. Expand
Diagnosis and Treatment of Chronic Prostatitis Caused by Chlamydia trachomatis
TLDR
Two diagnostic methods are compared: McCoy culture including immunofluorescent typing with monoclonal antibodies and DNA/RNA Digene hybridization method to prove C. trachomatis in expressed prostatic secretion (EPS) or voided bladder urine collected immediately after prostatic massage (VB3). Expand
[Role of levofloxacin in the treatment of urinary tract infections].
  • A. Trinchiere
  • Medicine
  • Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
  • 2001
TLDR
Acquired resistance of uropathogens to aminopenicillins and trimethoprim-sulfamethoxazole appears to have been increasing in the United States and Europe, while the susceptibility to systemic fluoroquinolones has remained unchanged at 98-99%. Expand
...
1
2
3
4
...